Please login to the form below

Not currently logged in
Email:
Password:

Roche Cobas

This page shows the latest Roche Cobas news and features for those working in and with pharma, biotech and healthcare.

Boehringer cancer drug on course for NHS use in UK

Boehringer cancer drug on course for NHS use in UK

Boehringer's drug will face two EGFR inhibitors already approved by NICE for NHS use: AstraZeneca and Teva's Iressa(gefitinib) and Roche's Tarceva(erlotinib). ... Recommended devices included Roche's cobas EGFR Mutation Test and Qiagen's therascreen EGFR

Latest news

  • Boehringer to work with Roche on cancer diagnostics Boehringer to work with Roche on cancer diagnostics

    Will collaborate with Roche subsidiary Ventana Medical Systems. Boehringer Ingelheim has taken another step forward with its fledgling oncology business by signing a deal with a Roche subsidiary to develop cancer ... Boehringer's choice of Roche-owned

  • NICE recommends tests to detect lung cancer mutation NICE recommends tests to detect lung cancer mutation

    These include Boehringer Ingelheim's Giotrif/ Gilotrif (afatinib) and Roche's Tarceva (erlotinib), both of which have specific approvals for use in patients with EGFR. ... Both medicines were also approved by the US Food and Drug Administration (FDA)

  • Boehringer breaks into oncology with FDA approval Boehringer breaks into oncology with FDA approval

    Roche and Astellas also received fast-track status in January for their cancer drug Tarceva to cover first-line treatment of NSCLC, receiving approval for this expanded indication in March. ... Tarceva was approved alongside Roche's own the cobas EGFR

  • Roche pays $220m for blood-testing company Roche pays $220m for blood-testing company

    The CMI acquisition will boost this division's current efforts in blood testing, which includes Roche's cobas series of analysers, although these are used across a wider range of conditions ... and was followed a month later by FDA approval of Roche's

  • US FDA approves Roche's assay as first blood test to diagnose diabetes US FDA approves Roche's assay as first blood test to diagnose diabetes

    Roche's Cobas Integra 800 Tina-quant HbA1cDx assay and other similar tools to measure blood sugar are already used to monitor the glucose control of people with diabetes, but this ... There is a difficulty in knowing which HbA1c tests are accurate enough

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Diagnostics are rising up the pharma value chain Diagnostics are rising up the pharma value chain

    Pharma interview: Anssi Pulkkinen from Roche Diagnostics, Finland on the increasing prominence of diagnostics. ... lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics